694
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Pre-analytical variables of circulating cell-free nucleosomes containing 5-methylcytosine DNA or histone modification H3K9Me3

, , , , , , & show all
Pages 448-453 | Received 17 Nov 2015, Accepted 13 May 2016, Published online: 13 Jun 2016

References

  • Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (Oxford). 1990;49:1374–403.
  • Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–49.
  • Jørgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29–32.
  • Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, Church TR. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106–14.
  • van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82–90.
  • Parente F, Boemo C, Ardizzoia A, et al. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy. Endoscopy. 2012;45:27–34.
  • Klabunde C, Blom J, Bulliard J-L, et al. Participation rates for organized colorectal cancer screening programmes: an international comparison. J Med Screen. 2015;22:119–26.
  • Nielsen HJ, Jakobsen KV, Danish Study Group on Early Detection of Colorectal Cancer, et al. Screening for colorectal cancer: possible improvements by risk assessment evaluation? Scand J Gastroenterol. 2011;46:1283–94.
  • Taber JM, Aspinwall LG, Heichman KA, et al. Preferences for blood-based colon cancer screening differ by race/ethnicity. Am J Health Behav. 2014;38:351–61.
  • Nielsen HJ, Danish Endoscopy Study Group on Colorectal Cancer Detection, Danish Colorectal Cancer Cooperative Group, et al. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals. Scand J Gastroenterol. 2011;46:60–9.
  • Vaiopoulos AG, Athanasoula KC, Papavassiliou AG. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges. Biochim Biophys Acta BBA Mol Basis Dis. 2014;1842:971–80.
  • Ralla B, Stephan C, Meller S, et al. Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies. Crit Rev Clin Lab Sci. 2014;51:200–31.
  • Holdenrieder S, Dharuman Y, Standop J, et al. Novel serum nucleosomics biomarkers for the detection of colorectal cancer. Anticancer Res. 2014;34:2357–62.
  • Leszinski G, Gezer U, Siegele B, et al. Relevance of histone marks H3K9me3 and H4K20me3 in cancer. Anticancer Res. 2012;32:2199–205.
  • Holdenrieder S, Von Pawel J, Nagel D, et al. Long-term stability of circulating nucleosomes in serum. Anticancer Res. 2010;30:1613–15.
  • Holdenrieder S, Mueller S, Stieber P. Stability of nucleosomal DNA fragments in serum. Clin Chem. 2005;51:1026–9.
  • Bulut O, Aslak KK, Levic K, et al. A randomized pilot study on single-port versus conventional laparoscopic rectal surgery: effects on postoperative pain and the stress response to surgery. Tech Coloproctol. 2015;19:11–22.
  • Kirkwood T. Geometric means and measures of dispersion. Biometrics. 1979;35:908–9.
  • Hayes DF, Bast RC, Desch CE, et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst. 1996;88:1456–66.
  • Frederiksen C, Lomholt AF, Davis GJ, et al. Changes in plasma TIMP-1 levels after resection for primary colorectal cancer. Anticancer Res. 2009;29:75–81.
  • Holdenrieder S, Stieber P, Bodenmüller H, et al. Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer J Int Cancer. 2001;95:114–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.